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1. Introduction 
Differences in the content and kinetic properties 
of the ADP, ATP translocator in mitochondria from 
various sources have been demonstrated (reviewed 
[ 1,2] ). Recently the translocator protein was isolated 
from several organs [3-51 and data were reported 
suggesting differences between immunological 
properties of this protein isolated from heart, liver 
and kidney mitochondria [5]. 
In this study a comparison of immunological 
properties of translocator protein of rat heart, liver 
and hepatoma by a radioimmunological technique 
revealed that the same antigenic determinant(s) 
related to ADP, ATP translocator protein are present 
in the mitochondria of all the above tissues. In addi- 
tion, the data obtained suggest hat antigenic proper- 
ties of translocator protein isolated from different 
sources are unequally modified during the isolation. 
2. Materials and methods 
The maintenance and propagation of Zajdela 
hepatoma and the isolation of mitochondria from the 
tumor and rat liver were done as detailed in [6] . Rat 
heart mitochondria were isolated by a procedure 
similar to that used for the preparation of liver mito- 
chondria with the exception that the isolation 
medium was supplemented with 10 mM KCl. Mito- 
chondria from respective sources were loaded with 
carboxyatractylate (CAT) and then extracted with 
Triton X-100 to solubilize ADP, ATP translocator 
protein as CAT-protein complex [7]. The extracts 
obtained after centrifugation of the Triton X-100 
treated mitochondria at 140 000 X g for 40 min were 
used in the radioimmunoassay. CAT-proteins were 
purified from these supernatant fractions by 
hydroxylapatite chromatography and gel filtration 
on Sepharose 6B as in [3,.5] . 
The binding of 35S-labeled CAT to mitochondria 
was measured according to [8]. SDS-polyacrylamide 
gel electrophoresis was performed as in [9] in the 
slab gels with 12-20% linear acrylamide gradient. 
The distribution of radioactivity in the gels was 
detected by autoradiography of dried [lo] gel slabs. 
Rabbit antisera against rat heart or rat liver CAT- 
protein were obtained using the immunization 
scheme in [5]. Immunodiffusion was done by the 
double diffusion agar plate technique of Ouchterlony 
in 0.9% agar plates. Second antibody (swine anti- 
rabbit IgG) was kindly supplied by Dr G. Russ. 
CAT-protein isolated from rat heart mitochondria 
was radioiodinated to a spec. radioact. 2 X lo3 cpm/ng 
protein using N-succinimidyl-3/Qhydroxy phenyl/ 
propionate (11). In competitive inhibition radio- 
immunoassay a limited amount of antiserum against 
rat heart CAT-protein (final dilution 2 X 106), a 
constant amount of radioiodinated CAT-protein 
from heart, and then varying amounts of unlabeled 
CAT-proteins or Triton X-100 extracts of mito- 
chondria from different sources were added to 
0.25 ml RIA buffer (0.8% NaCl, 0.02% KCl, 0.02% 
KH2P04, 0.92% NazHP04, 0.5% Triton X-100, 5 mM 
EDTA, 0.05% NaN3, 0.1% bovine serum albumin, 
pH 7.4). Final volume of the mixture was 0.275 ml. 
The mixture was incubated 1 h at 37°C and 4 days at 
4°C. Appropriate amounts of nonimmune serum and 
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of precipitating second antibody were then 
introduced into the samples and incubated 3 h at 
37°C. The precipitates were washed 3-times with RIA 
buffer and counted in a gamma-counter. 
Protein concentration was estimated according to 
[13] and in the presence of Triton X-100 as in [14] . 
3. Results and discussion 
The translocator protein isolated from rat heart, 
liver and hepatoma mitochondria as a CAT-protein 
complex exhibited identical electrophoretic mobility 
in SDS-polyacrylamide gel electrophoresis corre- 
sponding to mol. wt 30 000. Two different antisera 
against heart and liver CAT-proteins were prepared. 
In accordance with [S] , no crossreaction was 
detected between CAT-protein from rat liver and 
antibody against heart CAT-protein (fig.1) and 
vice versa in Ouchterlony double diffusion test. In addi- 
tion, neither of the two antisera reacted with the CAT- 
protein isolated from rat hepatoma mitochondria 
3 
Fig.1. Immunodiffusion reaction of CAT-protein from dif- 
ferent sources with antiserum against heart CAT-protein. 
Centre well, antiserum against rat heart CAT-protein. Other 
wells, equal concentrations of isolated CAT-protein from (1) 
rat heart, (2) liver and (3) hepatoma. 
when tested by the same technique. The data obtained 
by this technique with CAT-protein isolated from 
heart, liver and kidney mitochondria and antibody 
against heart CAT-protein had been interpreted in 
terms of an immunological organ specificity of this 
protein [5]. However, such an interpretation would 
require a corroboration by additional immunological 
technique, since in several studies [15,16] a cross- 
reaction of antigenic determinants could be 
demonstrated by radioimmunoassay in case when it 
hadnot been detected by conventional immunological 
methods. 
To examine whether the CAT-proteins from 
heart, liver and hepatoma mitochondria share common 
antigenic determinant(s) a competitive inhibition 
radioimmunoassay has been employed in this study. 
In the assay, heart CAT-protein as a labeled antigen 
and homologous heart CAT-protein antiserum were 
used. The isolated heart CAT-protein was electro- 
phoretically pure (fig.ZA), gave a single precipitin 
line in Ouchterlony double diffusion test (see fig.1). 
and after iodination retained its integrity and ability 
to interact with homologous antiserum (fig.ZB). In 
the competitive inhibition radioimmunoassay it was 
found that the CAT-protein isolated from hepatoma 
was able to inhibit the binding of labeled heart CAT- 
protein with homologous antibody almost completely, 
whereas only partial (25%) inhibition was obtained 
with the CAT-protein isolated from liver mitochondria 
even at the highest concentration used (fig.3A). One 
of the reasons why high concentrations of isolated 
hepatoma and liver CAT-protein are required to 
demonstrate a crossreaction with CAT-protein 
isolated from heart might be a modification of 
antigenic structure of these proteins during the 
isolation. To restrain such a modification, Triton 
X-100 solubilized CAT-loaded mitochondria were 
used instead of isolated CAT-proteins in Ouchterlony 
double diffusion and in the competitive inhibition 
radioimmunoassay. Triton X-lOO-solubilized mito- 
chondria from all the sources examined gave visible 
precipitin line with heart CAT-protein antibody. 
Yet, the use of detergent-solubilized membranes in 
immunodiffusion may lead to artifactual results 
[ 171. More conclusive data can be obtained using 
the competitive inhibition radioimmunoassay. In 
this assay almost complete inhibition of binding of 
the labeled CAT-protein isolated from heart with 
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Fig.2. SDS-polyacrylamide gel eiectrophoresis of isolated 
and immunoprecipitated rat heart CAT-protein. (A) 15 ~crg 
CAT-protein isolated from rat heart mitochondria were 
electrophoresed and stained. (B) ‘*‘I-labeled heart CAT- 
protein (2 X lo6 cpm) in RIA buffer was incubated with 
5 ~1 homologous antiserum for 5 min at room temperature. 
The precipitate formed after addition of second antibody was 
washed 5 times with RIA buffer, dissolved in 2’Z SDS, 8 M 
urea, 4% p-mercaptoethanol, 1070 glycerol, and heated for 
2 min at 100°C The sample was electrophoresed in the 
same slab as that to be stained, dried and autoradiographed. 
The position of molecular weight standards is indicated; 
cytochrome c (13 000), soybean trypsin inhibitor (21 000), 
chymotrypsinogen (26 OOO), bovine serum albumin (68 000). 
homologous antibody was obtained with detergent- 
solubilized mitochondria of all the sources examined 
(fig.3B). The extent of inhibition and the slope of the 
competition curves for purified heart CAT-protein 
and for solubilized mitochondria of heart, hepatoma 
and liver were almost equal. This indicates that all 
heart CAT-protein specific antigenic determinants 
involved in the radioimmunoassay under the condi- 
tions used, are present in the solubilized mitochondria 
of heart, liver and hepatoma. 
The use of solubilized mitochondria instead of 
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Fig.3, immunological cross-reactivity between CAT-proteins 
from rat liver, heart and hepatoma mitochondria. Competitive 
inhibition radioimmunoassay was performed as in section 2 
with ‘251-labeled heart CAT-protein (5 X 10” cpm/tube) and 
antiserum against heart CAT-protein (final dilution 2 X 10’). 
In the competition isolated CAT-protein trom (-o-) rat 
heart, (-A-) liver and (-0 -> hepatoma mitochondrra or 
Triton X-100-solubilized mitochondria from (-•-) rat heart, 
(-A-) liver and t-m-) hepatoma were used. 
isolated CAT-protein in the assay resulted not only 
in the complete inhibition of binding but also in the 
mutual approaching of competition curves for 
respective competing antigens. Lateral displacement 
of identical competition curves reflects a modification 
of antigenicity of all antigenic determinants involved 
in the assay [ 181. Thus the differences in the 
antigenicity of the CAT-proteins present in the 
respective solubilized mitochondria are smaller than 
those of corresponding isolated CAT-protein 
preparations. While the ratio of the competing protein 
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concentration required for 50% inhibition was 
1 : 40 : >lOOO for isolated CAT-proteins, the ratio 
of 1 : 5 : 50 was found for solubilized mitochondria 
of heart, hepatoma, and liver respectively. The 
amounts of CAT-protein in these mitochondria 
which bind to antibody raised against heart CAT- 
protein are proportional to the capacities of the mito- 
chondria to bind 35S-labeled CAT. It was found that 
Zajdela hepatoma mitochondria bind 0.35 pmol, 
rat liver - 0.15 pmol, and rat heart mitochondria - 
1.1 pmol 35S-labeled CAT/gram protein. Thus the 
differences in the antigenicity of the competing 
antigens present in the respective mitochondria after 
Triton X-l 00 solubilization are actually smaller than 
those indicated by the mutual distances between the 
competition curves. 
The differences in the ratios of the competing 
protein concentrations required for 50% inhibition 
using isolated antigens and solubilized mitochondria 
demonstrate an unequal attenuation of CAT-protein 
antigenicity during the purification of the antigen 
(hydroxylapatite chromatography and gel filtration) 
from respective solubilized mitochondria. It can be 
extrapolated that a similar, through less pronounced 
effect takes place also in the course of the solubiliza- 
tion of mitochondria. A lack of cross-reactivity 
between CAT-proteins isolated from different organs 
in Ouchterlony double diffusion test thus probably 
reflects an unequal modification of CAT-protein 
antigenicity by the solubilization and isolation. 
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